Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 November 2022 | Story André Damons

The Department of Pharmacology at the University of the Free State (UFS), together with the Technology Innovation Agency (TIA), is hosting the first Indigenous Knowledge and Bio-Trade Indaba on the Bloemfontein Campus. The Department of Science and Innovation (DSI) and TIA are the sponsors of the event. 

Prof Motlalepula Matsabisa, Professor and Director of Pharmacology, will play host to the various stakeholders to network and share knowledge on current developments in indigenous knowledge research and product development, biodiversity, innovation, and commercialisation of the IK-based research products. The Indigenous Knowledge System (IKS) for Health unit in the Department of Pharmacology within the UFS Faculty of Health Sciences was last year awarded an annual Technology Innovation Agency Platform (TIA) grant of R17 million for the next five years.

The research and teaching programme in the School of Clinical Medicine has since been rebranded and is now known as the African Medicines Innovation and Technology Development Platform (AMITD), which will strive to respond to community health needs and address industry research needs and challenges.

The indaba will showcase progress made by TIA and other entities in enriching the development and commercialisation of IK-based innovations. It will take place from 24 to 25 November 2022 in the Equitas Senate Hall at the UFS. 

Prof Matsabisa is the chairperson of the World Health Organisation’s (WHO) Regional Expert Advisory Committee on Traditional Medicines for COVID-19. He is also a visiting professor at the Beijing University of Chinese Medicine (BUCM) in Beijing, China, and the Deputy President of the South African Society for Basic and Clinical Pharmacology.
 

News Archive

OSM Camerata records CD with world-renowned cellist
2014-05-14

In 2010, South African cellist Heleen du Plessis, Executant lecturer for cello at the University of Otago, initiated the project “Cello for Africa”. The objective was to record a CD of new South African compositions for cello, reflecting the multi-cultural context of the country.

Du Plessis received an extensive research grant from the University of Otago in order to realise the project by commissioning, premièring and recording music. The aim was to facilitate a dialogue between Western and African musical traditions, as well as between the cello and indigenous African instruments.

Hans Huyssen, composer and cellist, has been closely involved in indigenous African music for a considerable time. In light of his extensive international experience, the SAMRO Foundation has granted Du Plessis' request to commission Huyssen to this task.

A world premiere concert preceded the recordings at the UFS’ Odeion School of Music (OSM) in March 2013, partially funded by a Humanities Research Grant as well as the OSM. This event provided a collaborative platform for musicians from different cultural backgrounds and several institutions to contribute towards a cultural and musical exchange. The funding enabled the project to successfully conclude in the recording of the CD, “Cello for Africa”. It was released by ODE records – the New Zealand label for classical music.

The OSM Camerata (OSMC) is the flagship ensemble of the OSM and was founded in 2012 with the main objective to kindle and forge the talents of exceptionally gifted students and pursue the highest artistic standards possible.

The OSMC participated in 2013 in the 13th International Conservatoire Festival hosted at the Rimsky Korsakov Conservatoire in St Petersburg, Russia. The OSMC received a standing ovation during their gala performance in the Glazonov Hall with a programme by South African composers Stefans Grové and Hendrik Hofmeyr.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept